home / stock / mdxg / mdxg quote
Last: | $6.56 |
---|---|
Change Percent: | 7.54% |
Open: | $6.35 |
Close: | $6.56 |
High: | $6.72 |
Low: | $6.28 |
Volume: | 261,058 |
Last Trade Date Time: | 11/03/2020 04:55:30 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.56 | $6.35 | $6.56 | $6.72 | $6.28 | 261,058 | 11-03-2020 |
$6.1 | $5.5 | $6.1 | $6.67 | $5.5 | 373,630 | 11-02-2020 |
$5.32 | $5.75 | $5.32 | $5.94 | $5.32 | 292,928 | 10-30-2020 |
$5.75 | $5.8 | $5.75 | $5.99 | $5.53 | 288,548 | 10-29-2020 |
$5.8 | $5.79 | $5.8 | $6.04 | $5.78 | 93,054 | 10-28-2020 |
$5.84 | $5.85 | $5.84 | $6 | $5.8 | 52,636 | 10-27-2020 |
$5.91 | $6 | $5.91 | $6.05 | $5.85 | 91,606 | 10-26-2020 |
$5.86 | $6.37 | $5.86 | $6.37 | $5.52 | 242,793 | 10-23-2020 |
$6.38 | $6.4245 | $6.38 | $6.45 | $6.32 | 635,430 | 10-22-2020 |
$6.41 | $6.42 | $6.41 | $6.49 | $6.4 | 42,425 | 10-21-2020 |
$6.47 | $6.41 | $6.47 | $6.5 | $6.4 | 16,885 | 10-20-2020 |
$6.6 | $6.6 | $6.6 | $6.6599 | $6.49 | 14,696 | 10-19-2020 |
$6.52 | $6.58 | $6.52 | $6.67 | $6.45 | 155,698 | 10-16-2020 |
$6.59 | $6.57 | $6.59 | $6.62 | $6.5 | 67,527 | 10-15-2020 |
$6.58 | $6.63 | $6.58 | $6.72 | $6.55 | 98,456 | 10-14-2020 |
$6.74 | $6.66 | $6.74 | $6.74 | $6.56 | 44,445 | 10-13-2020 |
$6.71 | $6.69 | $6.71 | $6.74 | $6.4 | 104,800 | 10-12-2020 |
$6.68 | $6.52 | $6.68 | $6.74 | $6.52 | 183,190 | 10-09-2020 |
$6.61 | $6.55 | $6.61 | $6.74 | $6.4 | 108,321 | 10-08-2020 |
$6.5 | $6.59 | $6.5 | $6.62 | $6.46 | 133,450 | 10-07-2020 |
News, Short Squeeze, Breakout and More Instantly...
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 3...
Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the Market Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Doubl...
MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered into an agreement with TELA Bio, Inc. to obtain exclusive rights to its manufacturing and supply agreement with Regenity ...